Email story to a friend
Printable version
GlaxoSmithKline wins approval for bird flu vaccine
Date: 19 May 2008
GlaxoSmithKline has been granted EU approval for a new vaccine designed to combat the feared outbreak of a human-spread variant of the H5N1 bird influenza.
The company's Prepandrix will become the first vaccine for use in this eventuality, and various governments have already begun to stockpile the drug for the possible instance that the virus mutates from being a disease almost exclusively affecting birds to one that could be deadly to humans.
Bookmark with:
Del.icio.us |
Digg |
reddit |
Facebook |
StumbleUpon
Comments
You must be logged in to add comments
Special Feature
Social responsibility and finance - on the precipice
In a recent article, the BBC's economics editor Robert Peston highlighted the fact that in 2012 the chances are that the economy - punch drunk as it is from the various flavours of debt crisis it has been pummelled with over the course of the year - will be hit by the collapse of a major bank and / or government.
Similar news stories
US: GlaxoSmithKline boss promises company has changed after $3bn mis-selling fine - 26 Jul 2012
Drug companies cut vaccine prices in search of a more humane business model - 6 Jun 2011
Japan: Astrazeneca settles claims over cancer drug side effects - 12 Jan 2011
US: Former GlaxoSmithkline executive charged as law targets individuals - 10 Nov 2010
From the same country
Ethical behaviour tied to better financial returns - 11 Jun 2008
SRI investors support UN business and human rights report - 11 Jun 2008
Business leaders lobby for carbon cuts - 20 Jun 2008
Anti-corruption enforcement strengthens but problems remain - 14 May 2008
Other stories about this company
US: GlaxoSmithKline boss promises company has changed after $3bn mis-selling fine - 26 Jul 2012
Drug companies cut vaccine prices in search of a more humane business model - 6 Jun 2011
US: Former GlaxoSmithkline executive charged as law targets individuals - 10 Nov 2010
US: GlaxoSmithKline could face $6bn risk over diabetes drug Avandia - 6 Mar 2010
UK: GlaxoSmithKline targets low cost vaccine for malaria - 21 Jan 2010
Kenya: GlaxoSmithKline agrees HIV royalty-free licensing to get medicines to the poor - 21 Jul 2009
Currently most popular stories
AccountAbility hits back at 'untenable' standards board (14 Jan 2011)
Peru: Pluspetrol in spotlight over Amazon rainforest pollution (27 Mar 2013)
Arguments against corporate social responsibility - redoubled (26 Oct 2008)
European CSR Alliance launched to NGO catcalls (24 Mar 2006)
China: Protests against polluting plants on the rise (30 Oct 2012)
No comments added - be the first!